Purchases and Sales Made in Q3 2024 in Pacira Bio Sciences, Inc. (PCRX)
This table provides information about the institutional ownership of Pacira Bio Sciences, Inc. (PCRX) during Q3 2024. The information is specifically focused on institutions that hold shares of Pacira BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-331K- 81.67% |
$3.87M - $9.43M
|
74.3K
$1.72M
|
|
|
Nov 14, 2024
Q3 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-385K- 49.04% |
$4.5M - $11M
|
400K
$9.27M
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-413K- 58.08% |
$4.83M - $11.8M
|
298K
$6.91M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-446K- 45.95% |
$5.22M - $12.7M
|
525K
$12.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-675K- 96.66% |
$7.9M - $19.2M
|
23.3K
$540K
|
|
|
Oct 28, 2024
Q3 2024
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-730K- 73.13% |
$8.54M - $20.8M
|
268K
$6.22M
|